Skip to main content
OpenTrials

Clinical trial condition

Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia

Explore clinical trials studying Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia. Study availability and eligibility vary by location and protocol.

3 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia trial results

Recruiting

A Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of B019 Injection in Subjects With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia.

NCT06927466

Conditions
Burkitt Lymphoma, DNA Virus Infections, Disease Attributes, +19 more
Locations
  • Peking University People's Hospital Beijing, China
  • Jiangxi Province pediatric hospital Nanchang, China
  • The First Affiliated Hospital of Nanchang University Nanchang, China
  • Children's Hospital of Shanghai Shanghai, China
View Trial Details

Related conditions